In silico testing and in vivo experiments with closed-loop control of blood glucose in diabetes

IFAC Proceedings Volumes (IFAC-PapersOnline)

Volumn 17, Issue 1 PART 1, 2008, Pages

  Kovatchev, Boris ^a   Raimondo, Davide Martino ^a   Breton, Marc ^a   Patek, Stephen D ^a   Cobelli, Claudio ^a  

^a NONE

Author keywords

Biomedical system modeling, simulation and visualization; Healthcare management, disease control, critical care; Quantification of physiological parameters for diagnosis and treatment assessment

Indexed keywords

BIOMEDICAL SYSTEM MODELING, SIMULATION AND VISUALIZATION; BLOOD GLUCOSE; CLINICAL STUDY; CLINICAL TRIAL; CLOSED-LOOP CONTROL; CONTINUOUS GLUCOSE MONITORING; CONTROL ALGORITHMS; DIABETES CARE; HEALTHCARE MANAGEMENT, DISEASE CONTROL, CRITICAL CARE; IN-SILICO; IN-VIVO; IN-VIVO EXPERIMENTS; INSULIN DELIVERY; INSULIN PUMPS; MATHEMATICAL MODELING; METABOLIC SYSTEMS; POSITIVE EFFECTS; QUANTIFICATION OF PHYSIOLOGICAL PARAMETERS FOR DIAGNOSIS AND TREATMENT ASSESSMENT;

ALGORITHMS; COMPUTATIONAL METHODS; COMPUTER SIMULATION; COMPUTER TESTING; DIAGNOSIS; DISEASE CONTROL; GAS BURNERS; GLUCOSE; HEALTH CARE; INSULIN; PHYSIOLOGICAL MODELS; VISUALIZATION;

CLOSED LOOP CONTROL SYSTEMS;

EID: 79961019786     PISSN: 14746670     EISSN: None     Source Type: Conference Proceeding    
DOI: 10.3182/20080706-5-KR-1001.2448     Document Type: Conference Paper

References (46)

1. E. F. Pfeiffer, C. H. Thum, and A. H. Clemens. The articial beta cell - A continuous control of blood sugar by external regulation of insulin infusion (glucose controlled insulin infusion system). Horm Metab Res, 487:339-442, 1974.
2. A. M. Albisser, B. S. Liebel, T. G. Ewart, Z. Davidovac, C. K. Botz, and W. Zinggg. An articial endocrine pancreas. Diabetes, 23:389-396, 1974.
3. A. H. Clemens, P. H. Chang, and R. W. Myers. The development of Biostator, a glucose-controlled insulin infusion system. Horm Metab Res Supplement, 7:23-33, 1977.
4. E. B. Marliss, F. T. Murray, E. F. Stokes, B. Zinman, A. F. Nakhooda, A. Denoga, B. S Leibel, and A. M. Albisser. Normalization of glycemia in diabetics during meals with insulin and glucagon delivery by the arti cial pancreas. Diabetes, 26:663-672, 1977.
5. J. V. Santiago, A. H. Clemens, W. L. Clarke, and D. M. Kipnis. Closed-loop and open-loop devices for blood glucose control in normal and diabetic subjects. Diabetes, 28:71-84, 1979. (Pubitemid 9103179)
6. E. W Kraegen, L. V. Campbell, Y. O. Chia, H. Meler, and L. Lazarus. Control of blood glucose in diabetics using an articial pancreas. Aust N Z J Med , 7:280-286, 1977.
7. U. Fischer, E. Jutzi, E-J. Freyse, and E. Salzsieder. Derivation and experimental proof of a new algorithm for the articial beta-cell based on the individual analysis of the physiological insulin- glucose relationship. Endokrinologie, 71:65-75, 1978.
8. A. H. Clemens. Feedback control dynamics for glucose controlled insulin infusion system. MedProg Technol., 6: 91-98, 1979. (Pubitemid 9213094)
9. H. M. Broekhuyse, J. D. Nelson, B. Zinman, and A. M. Albisser. Comparison of algorithms for the closed-loop control of blood glucose using the articial beta cell. IEEE Trans Biomed Eng, BME-28:678-687, 1981.
10. E. Salzsieder, G. Albrecht, U. Fischer, and E-J Freyse. Kinetic modeling of the gluco-regulatory system to improve insulin therapy. IEEE Trans Biomed Eng, 32: 846-855, 1985.
11. U. Fischer, W. Schenk, E. Salzsieder, G. Albrecht, P. Abel, and E-J Freyse. Does physiological blood glucose control require an adaptive strategy? IEEE Trans Biomed Eng, BME34:575-582, 1987. (Pubitemid 18072154)
12. J. T. Sorensen. A Physiologic Model of Glucose Metabolism in Man and its Use to Design and Assess Improved Insulin Therapies for Diabetes. Ph.D. dissertation, Department of Chemical Engineering, MIT, 1985.
13. R. L. Ollerton. Application of optimal control theory to diabetes mellitus. Int J Control, 50:2503-2522, 1989. (Pubitemid 20647118)
14. M. E. Fischer. A semi closed-loop algorithm for the control of blood glucose levels in diabetics. IEEE Trans Biomed Eng, 38:57-61, 1991.
15. H. Leblanc, D. Chauvet, P. Lombrail, and J. J. Robert. Glycemic control with closed-loop intraperitoneal insulin in type I diabetes. Diabetes Care, 9:124-128, 1986. (Pubitemid 16080465)
16. J. L. Selam, P. Micossi, F. L. Dunn, and D. M. Nathan. Clinical trial of programmable implantable insulin pump for type I diabetes. Diabetes Care, 15:877-885, 1992.
17. E. Renard. Implantable closed-loop glucose-sensing and insulin delivery: the future for insulin pump therapy. Current Opinion in Pharmacology, 2:708-716, 2002.
18. D. C. Klono. The Articial Pancreas: How Sweet Engineering Will Solve Bitter Problems. J Diabetes Sci Technol, 1:72-81, 2007.
19. G. M. Steil, K. Rebrin, C. Darwin, F. Hariri, and M. F. Saad. Feasibility of automating insulin delivery for the treatment of type 1 diabetes. Diabetes, 55:3344-3350, 2006. (Pubitemid 44923591)
20. S. Weinzimer. Closed-Loop Articial Pancreas: Feasibility Studies in Pediatric Patients with Type 1 Diabetes. Proc. 6th Diabetes Technology Meeting, S55, 2006.
21. Senate hearing: The Potential of an Articial Pancreas: Improving Care for People with Diabetes. September 27, 2006.
22. The JDRF e-Newsletter: Emerging Technologies in Diabetes Research. September, 2006.
23. D. M. Eddy, and L. Schlessinger. Validation of the Archimedes Diabetes Model. Diabetes Care, 26:3102-3110, 2003.
24. D. M. Eddy, and L. Schlessinger. Archimedes: A Trial- Validate Model of Diabetes. Diabetes Care, 26:3093-3101, 2003.
25. C. Dalla Man, R. A. Rizza, and C. Cobelli. Meal simulation model of the glucose-insulin system. IEEE Trans Biomed Eng, 54:1740-1749, 2007. (Pubitemid 47450539)
26. C. Dalla Man, D. M. Raimondo, R. A. Rizza, and C. Cobelli. GIM, Simulation Software of Meal Glucose- Insulin Model. J Diabetes Science and Technology, 1(3): 323-330, 2007.
27. M. Gerritsen, J. A. Jansen, and J. A. Lutterman. Performance of subcutaneously implanted glucose sensors for continuous monitoring. Neth J Med, 54:167-179, 1999.
28. T. M. Gross, B. W. Bode, D. Einhorn, D. M. Kayne, J. H. Reed, N. H. White, and J. J. Mastrototaro Performance evaluation of the MiniMed continuous glucose monitoring system during patient home Use. Diabetes Technol Ther, 2:49-56, 2000.
29. E. H. Cheyne, D. A. Cavan, and D. Kerr. Performance of continuous glucose monitoring system during controlled hypoglycemia in healthy volunteers. Diabetes Technol Ther, 4:607-613, 2002. (Pubitemid 35283323)
30. B. P. Kovatchev, L. A. GonderFrederick, D. J. Cox, and W. L. Clarke. Evaluating the accuracy of continuous glucose monitoring sensors: Continuous Glucose Error-Grid Analysis (CG-EGA) illustrated by Therasense Freestyle Navigator data. Diabetes Care, 27:1922-1928, 2004.
31. W. L. Clarke, S. Anderson, L. S. Farhy, M. Breton, L. A. Gonder-Frederick, D. J. Cox, and B. P. Kovatchev, L. A. Gonder-Frederick, D. J. Cox, and W. L. Clarke. Evaluating the Clinical Accuracy of Two Continuous Glucose Sensors Using Continuous Glucose-Error Grid Analysis (CG-EGA). Diabetes Care, 28:2412-2417, 2005.
32. W. L. Clarke, and B. P. Kovatchev, Continuous glucose sensors - continuing questions about clinical accuracy. J Diabetes Sci Technol, 1:164-170, 2005.
33. H. Zisser, S. Shwartz, R. Rather, J. Wise, T. Bailey. Accuracy of a seven-day continuous glucose sensor compared to YSI blood glucose values. In Proceedings of the 27th workshop of the AIDPIT Study Group, Innsbruck, Austria, 2008. , AIDPIT p.S03 available from http://www.aidpit.org.
34. C. R. King, S. M. Anderson, M. D. Breton, W. L. Clarke, and B. P. Kovatchev. Modeling of Calibration Eectiveness and Blood-to-Interstitial Glucose Dynamics as Potential Confounders of the Accuracy of Continuous Glucose Sensors. J Diabetes Sci Technol, 1:317-322, 2007.
35. G. Nucci, and C. Cobelli. Models of subcutaneous insulin kinetics. A critical review. Comput Methods Programs Biomed., 62:249-257, 2000.
36. M. E. Wilinska, L. J. Chassin, H. C. Schaller, L. Schaupp, T. R. Pieber, R. Hovorka. Insulin kinetics in type-1 diabetes: continuous and bolus delivery of rapid acting insulin. IEEE Trans. Biomed. Eng., 52(1):3-12, 2005.
37. D. C. Klono. Continuous glucose monitoring: Roadmap for 21st century diabetes therapy. Diabetes Care, 28: 1231-1239, 2005.
38. K. Garg, H. Zisser, S. Schwartz, T. Bailey, R. Kaplan, S. Ellis, L. Jovanovic. Improvement in Glycemic Excursions With a Transcutaneous, Real-time Continuous Glucose Sensor. Diabetes Care, 29:44-50, 2006.
39. D. Deiss, J. Bolinder, J. Riveline, T. Battellino, E. Bosi, N. Tubiana-Ru, D. Kerr, M. Phillip Improved Glycemic Control in Poorly Controlled Patients with Type 1 Diabetes Using Real-Time Continuous Glucose Monitoring. Diabetes Care, 29:2730-2732, 2006.
40. B. P. Kovatchev, W. L. Clarke. Continuous Glucose Monitoring (CGM)) reduces risks for hypo- and hyperglycemia and glucose variability in T1DM and insulintreated T2DM. Diabetes, 56(Suppl 1):A23, 2007.
41. B. P. Kovatchev, W. L. Clarke. Continuous Glucose Monitoring (CGM) Reduces Risks for Hypo- and Hyperglycemia and Glucose Variability in Diabetes. Diabetes, 56(Suppl 1):0086OR, 2007.
42. B. P. Kovatchev, W. L. Clarke, M. Breton, K. Brayman, A. McCall. Quantifying Temporal Glucose Variability in Diabetes via Continuous Glucose Monitoring: Mathematical Methods and Clinical Application. Diabetes Technology and Therapeutics, 7:849-862, 2005.
43. A. McCall, D. J. Cox, J. Crean, M. Gloster, and B. P. Kovatchev. A Novel Analytical Method for Assessing Glucose Variability: Using CGMS in Type 1 Diabetes Mellitus. Diabetes Technology and Therapeutics, 8:644-653, 2006.
44. R.Hovorka, L. J. Chassin, M. E. Wilinska, V. Canonico, J. A. Akwi, and M. Orsini-Federici. Closing the loop: the Adicol experience. Diabetes Technol Ther, 6:307-318, 2004.
45. R.Hovorka. Continuous glucose monitoring and closedloop systems. Diabetic Medicine, 23:1-12, 2005.
46. F. H. El-Khatib, J. Jiang, E. R. Damiano. Adaptive closed-loop control provides blood-glucose regulation using dual subcutaneous insulin and glucagon infusion in diabetic swine. Diabetes Sci Tech, 1:181-192, 2007.